Wearable Injectors Market Size, Share and Trends 2025 to 2034

Wearable Injectors Market Size and Forecast 2025 to 2034

The global wearable injectors market size was projected at USD 10.39 billion in 2024 and is anticipated to worth around USD 12.28 billion by 2025, to approximately USD 52.89 billion by 2034, growing at a CAGR of 17.67% from 2025 to 2034.

Wearable Injectors Market Key Takeways

• North America led the global market with the highest market share of 34% in 2024.
• Asia-Pacific is predicted to expand at the fastest CAGR during the forecast period.
• By Type, the on-body segment held the largest market share of 56% in 2024.
• By Type, the off-body segment is anticipated to grow at a remarkable CAGR during the projected period.
• By Application, the oncology segment had the biggest market share of 12% in 2024.
• By Application, the autoimmune diseases segment is estimated to expand at the fastest CAGR over the projected period.
• By End-use, the homecare segment contributed more than 81%  of revenue share in 2024.

U.S. Wearable Injectors Market Size and Growth 2025 to 2034

The global wearable injectors market size was exhibited at USD 2.47 billion in 2024 and is expected to be worth around USD 12.69 billion by 2034, at a CAGR of 18% from 2025 to 2034.

North America dominated the global wearable injector market in 2024, in terms of revenue and is estimated to sustain its dominance during the forecast period. This is attributed to the increased number of people suffering from various chronic diseases. According to a study, around 60% of the US population is suffering from at least one chronic disease. Moreover, the development of various innovative drugs that can effectively treat chronic diseases is fueling the demand for the wearable injector market. Moreover, the rising popularity of personalized medicines may impact the market positively in the forthcoming years.

Asia Pacific is estimated to be the most opportunistic market during the forecast period. Asia Pacific is home to several top biopharmaceutical manufacturers. The nations like India, China, and South Korea are expected to present lucrative opportunities to market players in the upcoming future. Moreover, the rising old-age population in the region is expected to drive the demand for wearable injectors. Geriatric people are more prone to various chronic diseases and are expected to foster market growth in the foreseeable future. According to the WHO, by 2050, around 80% of the geriatric population will be living in low and middle-income economies.

Market Overview

Wearable Injectors are medical devices that are worn on the body to inject drugs. They are an alternative to traditional syringes and are used to administer insulin to diabetes patients. The wearable injectors market is experiencing significant growth due to the rising trend of self-medication and the demand for home-based treatment. Thus, people are seeking ways to manage their health independently. However, these injectors allow people to take their medications on their own, reducing discomfort and improving overall health outcomes.

Wearable Injectors Market Growth Factors

The inconveniences like needle stick injuries and limitations of traditional syringes have encouraged the adoption of the latest wearable injectors among the population. The wearable injectors eliminate the requirement of any assistance from healthcare workers and also reduce the consumer’s expenditure on healthcare. Moreover, the wearable injectors are compact and portable and allow the patient to self-administer the drugs while conveniently doing regular tasks at home or office. All these benefits offered by wearable injectors are expected to drive the demand for wearable injectors among the population during the forecast period. Moreover, technological advancements led to the development of new and innovative drugs, which requires special drug delivery devices to efficiently administer the drugs in the patient’s body. Thus rapidly growing biopharmaceutical industry is boosting the development of new and innovative drugs that subsequently fosters the growth of the global wearable injector market across the globe.

The global wearable injector market is primarily driven by the growing prevalence of various chronic diseases such as cancer, rheumatoid arthritis, diabetes, cardiovascular diseases, and other chronic diseases coupled with technological advancements in drug delivery devices. Moreover, CVD accounted for around 32% of global deaths in 2019. The rapid growth of the biopharmaceuticals and development of various drugs that can cure chronic diseases efficiently fostered the demand for drug delivery devices across the globe.

Market Scope

Market Dynamics

Drivers

Chronic Disease Burden

The growing prevalence of chronic diseases, such as cancer, rheumatoid arthritis, diabetes, cardiovascular diseases, and other chronic diseases, is a major factor driving the global wearable injectors market. Some chronic diseases, such as dibetes, often require regular medication to manage symptoms, which significantly boosts the demand for wearable injectors. According to the World Health Organization (WHO), chronic diseases kill about 41 million people every year, which is equivalent to 74% of all deaths worldwide.

Restraint

High Cost

Wearable injectors are expensive, which may deter potential users from adopting them. This, in turn, limits their widespread adoption. Moreover, the availability of oral insulin as alternative method for drug delivery is expected to hamper the market. Oral insulin is easy to take, effective, and safe, thereby boosting their demand.

Opportunity

Technological Advancements

Technological advancements in drug delivery devices create immense opportunities in the wearable injectors market. Advancements in design are making drug delivery devices, including wearable injectors, user-friendly. Moreover, the rising demand for personalized treatments that can cure chronic diseases efficiently boosts the demand for drug delivery devices across the globe.

Type Insights

The on-body segment accounted for over 56% of the market share in 2024. The on-body wearable injectors are easy to wear and comfortable for the skin. This has led to the extensive adoption of on-body injectors, thereby propelling the growth of this segment. Moreover, the rising demand for home care is expected to boost the segment’s growth in the forthcoming years.

The off-body is estimated to be the fastest-growing segment during the forecast period. The off-body wearable injectors eliminate certain inconveniences such as adhesive fitting on the skin, painful removal of injectors, and skin irritation. The rising investments in the development of enhanced off-body injectors are expected to drive the growth of this segment in the future.

Application Insights

The oncology segment dominated the global wearable injector market in 2024, in terms of revenue and is estimated to sustain its dominance during the forecast period. This is attributed to the increased prevalence of cancer among the population. The increased prevalence of various cancer such as breast cancer, lung cancer, bowel cancer, and womb cancer are the major drivers of this segment.

On the other hand, autoimmune diseases are estimated to be the most opportunistic segment during the forecast period. This can be attributed to the rising prevalence of diabetes among the population and the rising demand for wearable injectors over traditional insulin pumps. According to the World Health Organization, diabetes is the major cause of kidney failure, heart attacks, blindness, and stroke. Hence, the demand for the treatment for diabetes is expected to drive the growth of this segment.

End User Insights

The homecare segment accounted for over 41% of the market share in 2024. The increased awareness regarding wearable injectors and increasing preferences for self-injecting of drugs. Moreover, the reduction in the costs of healthcare associated with the homecare segment and the elimination of any assistance for the administration of drugs using wearable injectors are the major drivers of this segment.

Wearable Injectors Market Companies

• Amgen
• Becton, Dickinson and Company
• Dexcom, Inc.
• Enable Injections
• Insulet Corporation
• Sensile Medical
• Tandem Diabetes Care, Inc.
• Ypsomed
• F. Hoffmann-La Roche Ltd
• Johnson and Johnson Private Ltd

Recent Developments

• In May 2024, Enable Injections partnered with Viridian Therapeutics, Inc. to enhance patient experience using enFuse, an innovative wearable drug delivery system.
• In April 2024, Medtronic introduced a wearable injector that can be worn by patients for 7 days for the treatment of diabetes.

Segments Covered in the Report

By Type

• On-Body
• Off-Body
• Hand Held

By Application

• Oncology
• Cardiovascular Diseases
• Infectious Diseases
• Autoimmune Diseases
• Others

By End User

• Hospitals
• Clinics
• Homecare
• Others

By Region

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa